Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report released on Monday. The brokerage set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Trading Up 6.0 %

Arcadia Biosciences stock opened at $6.40 on Monday. The firm has a market cap of $8.70 million, a price-to-earnings ratio of -1.50 and a beta of 1.19. The stock has a fifty day simple moving average of $3.56 and a two-hundred day simple moving average of $3.15. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.